Literature DB >> 795035

Chemotherapy: the agents in current use.

V A Levin, C B Wilson.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 795035

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  13 in total

Review 1.  Intrathecal chemotherapy with antineoplastic agents in children.

Authors:  A Ruggiero; V Conter; M Milani; E Biagi; I Lazzareschi; P Sparano; R Riccardi
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Cerebral astrocytomata--trends in radiotherapy and chemotherapy: a review.

Authors:  A Jones
Journal:  J R Soc Med       Date:  1978-09       Impact factor: 5.344

3.  Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases.

Authors:  M Nagane; A Levitzki; A Gazit; W K Cavenee; H J Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

4.  Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma.

Authors:  T E Elliott; R P Dinapoli; J R O'Fallon; J E Krook; J D Earle; R F Morton; R Levitt; L K Tschetter; B W Scheithauer; D M Pfeifle; D I Twito; R A Nelimark
Journal:  J Neurooncol       Date:  1997-07       Impact factor: 4.130

5.  The application of brain capillary permeability coefficient measurements to pathological conditions and the selection of agents which cross the blood-brain barrier.

Authors:  V A Levin; H D Landahl; M A Freeman-Dove
Journal:  J Pharmacokinet Biopharm       Date:  1976-12

6.  In vitro cellular characteristics and survival responses of human astrocytoma clones to chloroethyl-nitrosoureas and dianhydrogalactitol.

Authors:  N H Rubin; C Casartelli; B G Macik; W R Boerwinkle; S C Barranco
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

Review 7.  Chemotherapy of malignant gliomas.

Authors:  Y Ushio; T Hayakawa; H Hasegawa; K Yamada; N Arita
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

8.  Experimental chemotherapy with N'N'-bis(2-chloroethyl)-N-nitrosourea (BCNU) in autochthonous neurogenic tumors of the rat transplacentally induced by ethylnitrosourea.

Authors:  H H Fiebig; H Strobel; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

9.  Malignant gliomas treated after surgery by combination chemotherapy and delayed irradiation. Part I: Analysis of results.

Authors:  M Poisson; P Pouillart; J P Bataini; R Mashaly; B F Pertuiset; J Metzger
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

10.  A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors.

Authors:  L G Feun; D J Stewart; M E Leavens; M A Burgess; N Savaraj; R S Benjamin; G P Bodey
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.